Thorne HealthTech Inc. and its leadership allegedly filed a misleading solicitation statement last week ahead of a proposed buyout by L Catterton Management Ltd. affiliates, a shareholder suit says.
Shareholders can’t vote to approve the deal without key information on the financial projections and other data about the deal that financial adviser Canaccord Genuity LLC based its fairness opinion upon, according to the complaint filed Thursday in the US District Court for the Southern District of New York.
The proposed deal reached by the companies on Aug. 17 would pay out $10.20 per share for each outstanding share of Thorne ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.